Another experimental Alzheimer’s disease treatment has failed in a late-stage study. Takeda Pharmaceutical and development partner Zinfandel Pharmaceuticals have pulled the plug on their five-year Phase III TOMMORROW trial following an interim analysis. The two companies […]
Has the amyloid plaque question in Alzheimer’s research been put to rest? Eli Lilly’s recent data analysis of its failed Phase III Alzheimer’s disease treatment solanezumab would suggest so. In an article in the New […]
A review of data from 43 trials suggests that prenatal vitamin D has positive neonatal outcomes, but the current evidence base does not cover all aspects of outcomes and safety There is conflicting evidence and […]
Recent laboratory findings have indicated that the proton-pump inhibitor (PPI) lansoprazole is highly active against Mycobacterium tuberculosis, but there has been no clinical research into this effect. In a paper in PLoS Medicine (21 November […]
Available at 10:30 (GMT – 5:00) Eastern US and Canada time on 23 January, the webinar will discuss liposomes, which have been used in drug discovery and drug delivery for some time. The biophysical characterisation […]